Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate vs Prednisolone Acetate in Endogenous Anterior Uveitis
NCT00501579Phase 3Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of difluprednate in anterior uveitis (AU) (2 arms), sponsored by Sirion Therapeutics, Inc. Primary endpoint: Change in Anterior Chamber Cell Grade from Baseline at 14 days. Status: completed.
02
Drugs
difluprednate
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT00501579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501579.